Annual Review of Systemic Disease-1997-II

Journal of Neuro-Ophthalmology

Volumn 18, Issue 2, 1998, Pages 127-142

  Lama, Paul ^a   Frohman, Larry ^a,b,c  

^a INSTITUTE OF OPHTHALMOLOGY AND VISUAL SCIENCE   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c NONE   (United States)

Author keywords

HIV; Neuro opthalmic disorders; Ocular disease; Sarcoidosis; Tuberculosis

Indexed keywords

ALLOPURINOL; ATOVAQUONE; AZATHIOPRINE; CHLORAMBUCIL; CLINDAMYCIN; CYCLOPHOSPHAMIDE; DELAVIRDINE; DIDANOSINE; ETHAMBUTOL; GAMMA INTERFERON; INDINAVIR; ISONIAZID; LAMIVUDINE; METHOTREXATE; NELFINAVIR; NEVIRAPINE; PREDNISONE; PYRAZINAMIDE; PYRIMETHAMINE; RIFAMPICIN; RITONAVIR; SAQUINAVIR; STAVUDINE; SULFADIAZINE; ZALCITABINE; ZIDOVUDINE;

ANTIBIOTIC THERAPY; BACTERIUM IDENTIFICATION; BLOOD TOXICITY; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; EYE DISEASE; GASTROINTESTINAL TOXICITY; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHADENOPATHY; MYCOBACTERIUM TUBERCULOSIS; MYOPATHY; NEPHROLITHIASIS; PANCREATITIS; PRIORITY JOURNAL; REVIEW; SARCOIDOSIS; TOXOPLASMOSIS; TREATMENT PLANNING; TUBERCULOSIS; VISUAL IMPAIRMENT;

EID: 0031806775     PISSN: 10708022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041327-199806000-00012     Document Type: Review

References (112)

1. Barnes PF, Barrows SA. Tuberculosis in the 1990's. Ann Intern Med 1993;119:400-10.
2. Cohn DL, Bustreo F, Raviglione MC. Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD global surveillance project. International Union Against Tuberculosis and Lung Disease. Clin Infect Dis 1997;1(suppl 24):S121-30.
3. Kamholz SL. Resurgence of tuberculosis: the perspective a dozen years later. J Assoc Acad Minor Phys 1996;7(3):83-6.
4. Chin PK, Jacobs MB, Hing SJ. Orbital tuberculoma masquerading as an orbital malignancy. Aust NZJ Ophthalmol 1997;25(1): 67-9.
5. Zoric LD, Zoric DL, Zoric DM. Bilateral tuberculous abscesses on the face (eyelids) of a child. Am J Ophthalmol 1996;121(6): 717-8.
6. Kadioglu HH, Gundogdu C, Deniz O, et al. Optochiasmatic tuberculoma-case report and review. Zentralbl Neurochir 1996;57 (1):30-6.
7. Berinstein DM, Gentile RC, McCormick SA, Walsh JB. Primary choroidal tuberculoma. Arch Ophthalmol 1997;115(3):430-1.
8. Reny JL, Challe G, Geisert P, et al. Tuberculosis-related retinal vasculitis in an immunocompetent patient. Clin Infect Dis 1996; 22(5):873-4.
9. Berger C, Braegger CP, Albisetti M, et al. Cerebral tuberculosis presenting as complex febrile convulsions. Neuropediatrics 1996; 27(3):161-3.
10. Muccioli C, Belfort R Jr. Presumed ocular and central nervous system tuberculosis in a patient with the acquired immunedeficiency syndrome. Am J Ophthalmol 1996;121(2):217-9.
11. Bouza E, Merino P, Munoz P, et al. Ocular tuberculosis: a prospective study in a general hospital. Medicine 1997;76(1):53-61.
12. Piersimoni C, Callegaro A, Nista D, et al. Comparative evaluation of two commercial amplification assays for direct detection of mycobacteria tuberculosis complex in respiratory specimens. J Clin Microbiol 1997;35(1):193-6.
13. Wilkinson RJ, Haslov K, Rappuoli R, et al. Evaluation of the recombinant 38-kilodalton antigen of mycobacterium tuberculosis as a potential immunodiagnostic reagent. J Clin Microbiol 1997;35(3):553-7.
14. Kawamura M, Sueshige N, Imayoshi K, et al. Enzyme immunoassay to detect antituberculous glycolipid antigen (anti-TBGL antigen) antibodies in serum for diagnosis of tuberculosis. J Clin Lab Anal 1997;11(3):140-5.
15. Iseman M. Treatment of multidrug-resistant tuberculosis. N Engl J Med 1993;329(11):784-91.
16. Centers for Disease Control. Initial therapy for tuberculosis in the era of multidrug-resistance: recommendations of the advisory council for the elimination of tuberculosis. MMWR CDC Surveill Summ 1993;42(RR-7):1-8.
17. Peloquin CA. Pharmacology of the antimycobacterial drugs. Med Clin North Am 1993;77:1253-62.
18. Peloquin CA. Quinolones and tuberculosis. Ann Pharmacother 1996;30:1034-5.
19. Kaplan J, Krieff D. Quinolones for treatment and prophylaxis of TB. Ann Pharmacother 1996:30:1020-2.
20. Kohno S, Koga H, Kaku M, et al. Prospective comparative study of ofloxacin or ethambutol for the treatment of pulmonary tuberculosis. Chest 1993;104:1194-8.
21. Mohanty KL, Dhamgaye TM. Controlled trial of ciprofloxacin short-term chemotherapy for pulmonary tuberculosis. Chest 1993:104;1194-8.
22. Vilcek J, Oliveira I. Recent progress in the elucidation of interferon-gamma actions: molecular biology and biological functions. Int Arch Allergy Immunol 1994;104:311-6.
23. Holland SM, Eisenstein EM, Kuhus DB, et al. Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma: a preliminary report. N Engl J Med 1994; 330:1348-55.
24. Squires KE, Brown ST, Armstrong DA, et al. Interferon-gamma treatment for mycobacterium avium-intracellulare complex bacillemia in patients with AIDS (letter). J Infect Dis 1992;166:686-7.
25. Murray HW. Interferon-gamma and host antimicrobial defense: current and future clinical applications. Am J Med 1994;97:459-67.
26. Raad I, Hachem R, Leeds N, et al. Use of adjunctive treatment with interferon-gamma in an immunocompromised patient who had refractory multidrug-resistant tuberculosis of the brain. Clin Infect Dis 1996;22(3):572-4.
27. Condos R, Rom WN, Schluger NW. Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma aerosol. Lancet 1997;349(9064):1513-5.
28. Centers for Disease Control. Tuberculosis morbidity: United States, 1995. MMWR CDC Surveill Summ 1996;45(18):365-70.
29. Jabs DA, Johns CJ. Ocular involvement in chronic sarcoidosis. Am J Ophthalmol 1986;102:297-301.
30. Khomenko AG, Ozerova LV. Clinical aspects and characteristics of the course of most common non-pulmonary localizations of sarcoidosis. Vestn Ross Akad Med Nauk 1995;7:21-4.
31. Borodulina EA, Branchevskaia SI, Borodulin BE. Eye lesions in patients with pulmonary sarcoidosis. Vestn Oftalmol 1996; 112:50-1.
32. Makarov AI, Turicin VI, Kostina ZI. The diagnosis and treatment of neurosarcoidosis. Zh Nevropatol Psikhiatr 1995;95:90-3.
33. Recio V, Chistofondis G, Skarf B, Sundar G. Clinical and radiological analysis of neurosarcoidosis. Presented at the 1997 North American Neuro-Ophthalmology Society Meeting, Keystone, Colorado, February 1997.
34. Richter E, Greinert U, Kirtsen D, et al. Assessment of mycobacterial DNA in cells and tissue of mycobacteria and sarcoid lesions. Am J Respir Crit Care Med 1996;153:375-80.
35. Baselga E, Baradas MA, Margall N, de Moragas JM. Detection of tuberculosis complex DNA in a lesion resembling sarcoidosis. Clin Exp Dermatol 1996;21:235-8.
36. Almenoff PL, Johnson A, Lesser M, Mattman LH. Growth of acid fast L forms from the blood of patients with sarcoidosis. Thorax 1996;51:530-3.
37. el-Zaatari FA, Naser SA, Markesich DC, Kalter DC, Engstand L, Graham DY. Identification of mycobacterium avium complex in sarcoidosis. J Clin Microbiol 1996;34:2240-5.
38. el-Zaatari FA, Graham DY, Samuelsson K, Engstrand L. Detection on mycobacterial avium complex in cerebrospinal fluid of a sarcoid patient by specific polymerase reaction assays. Scand J Infect Dis 1997;29:202-4.
39. Puölakkainen M, Campbell LA, Kuo C-C, Leinonen M, Gronhagen-Riska C, Saikku P. Serological response to chlamydia pneumoniae in patients with sarcoidosis. J Infect 1996;33:199-205.
40. Tsukada N, Yanigasawa N, Mochizuki I. Endothelial cell damage in sarcoidosis and neurosarcoidosis: autoantibodies to endothelial cells. Eur Neurol 1995;32:108-12.
41. Milburn HJ, Poulter LW, Milmec A, Cochrane GM, Kemeny DM. Corticosteroids restore the balance between locally produced Th1 and Th2 cytokines and immunoglobulin isotypes to normal in sarcoid lung. Clin Exp Immunol 1997;108:105-13.
42. Kosmorsky GS, Prayson R. Primary optic pathway sarcoidosis in a 38-year-old white man. J Neuro-Ophthalmol 1996;16:188-90.
43. Ing EB, Garrity JA, Cross SA, Ebersold MJ. Sarcoid masquerading as optic nerve sheath meningioma. Mayo Clin Proc 1997; 72:38-13.
44. el Zarka A, Hille K, Ruprecht KW. Granulomatous process of the optic papilla as an initial sign of systemic sarcoidosis. Klin Monatsbl Augenheilkd 1995;206:134-5.
45. Ng KL, McDermott N, Romanowski CAJ, Jackson A. Neurosarcoidosis masquerading as glioma of the optic chiasm in a child. Postgrad Med J 1995;71:265-8.
46. Kao SC, Rootman J. Unusual orbital presentations of dural sarcoidosis. Can J Ophthalmol 1996;31:195-200.
47. Monfort-Gouraud M, Chokre R, Dubiez M, Ratsimiah T, Hamza A, Sauvageon G. Inflammatory pseudotumor of the orbit and suspected sarcoidosis. Arch Pediatr 1996;3:697-700.
48. Leiba H, Siatkowski RM, Culbertson WW, Glaser JS. Neurosarcoidosis presenting as an intracranial mass in childhood. J Neuro-Ophthalmol 1996;16:269-73.
49. Lee Andrew G. Unusual ocular feature to the possible protean manifestations of sarcoidosis [Letter/Comment]. Retina 1996;16: 266-7.
50. Rizzato G, Angi M, Fraioli P, Montemuuro L, Pilotto E, Tommasini A. Uveitis as a presenting feature of chronic sarcoidosis. Eur Respir J 1996;9:1201-5.
51. Braun M, Jonas JB. Band-like corneal degeneration as the initial sign of sarcoidosis. Klin Monatsbl Augenheilkd 1006;209:328-9.
52. DeRosa AJ, Margo CE, Orlick ME. Hemorrhagic retinopathy as the presenting manifestation of sarcoidosis. Retina 1995;15: 422-7.
53. Dodds EM, Lowder CY, Barnhorst DA, Lavertu P, Caravella LP, White DE. Posterior scleritis with annular ciliochoroidal detachment. Am J Ophthalmol 1995;120:677-9.
54. Vrabec TR, Augsburger JJ, Fischer DH, Belmont JB. Taches de bougie. Ophthalmology 1995;102:1712-21.
55. Caparros-Lefebvre, Wallaert B, Girard-buttaz I, et al. MRI aspect and course of supra-tentorial sarcoidosic lesions. Rev Neurol 1996;153:196-201.
56. Grand S, Hoffman D, Bost F, Francois-Joubert A, Pasquier B, Le Bas JF. Case report: pseudotumoral brain lesion as the presenting feature of sarcoidosis. Br J Radiol 1996;69:272-5.
57. Weissman MN, Lange R, Kelley C, Belgea K, Abel L. Intraspinal epidural sarcoidosis: case report. Neurosurgery 1996;39:179-81.
58. Waubant E, Manelfe C, Bonafe A, Berry I, Clnet M. MRI of intramedullary sarcoidosis: follow-up of a case. Neuroradiology 1997;39:357-60.
59. Fitzpatrick KJ, Chancellor MB, Rivas DA, Kumon H, Mandel S, Manon-Espaillat R. Urologic manifestation of spinal cord sarcoidosis. J Spinal Cord Med 1996;19:201-3.
60. Caviness JN, Knox CA. Hemisdystonia occurring in a patient with sarcoidosis. Mov Disord 1996;11:340-1.
61. De Bleecker J, van Aken L, van Landegem W, van den Abeele G, Cuvelier C. Myasthenia gravis and sarcoidosis: report of 2 cases. Eur Neurol 1996;36:326-7.
62. Jamrozik Z, Dabrowski A, Drac H, Kwiecinski H. Neurosarcoidosis or Guillain-Barre syndrome complicating sarcoidosis. Neurol Neurochir Pol 1996;30:481-7.
63. Sekiguchi M, Yazaki Y, Isobe, Hiroe M. Cardiac sarcoidosis: diagnostic, prognostic, and therapeutic considerations. Cardiovasc Drugs Ther 1996:10:495-510.
64. Nelson JE, Kirschner PA, Teirstein AS. Sarcoidosis presenting as heart disease. Sarcoidosis Vasc Diffuse Lung Dis 1996;13:178-82.
65. Vatti R, Sharma OP. Course of asymptomatic liver involvement in sarcoidosis: role of therapy in selected cases. Sarcoidosis Vasc Diffuse Lung Dis 1997;14:73-6.
66. Boruchowicz A, Hachulla E, Cortot A, Paris JC, Colombel JF. Chronic pancreatitis: a complication of sarcoidosis? Eur J Gastroenterol Hepatol 1996;8:1125-7.
67. Pearce KF, Nolan TE. Endometrial sarcoidosis as a cause of postmenopausal bleeding: a case report. J Reprod Med 1996;41: 878-80.
68. Sherman MD, Pince KJ, Farahmand SM. Sarcoidosis manifesting as uveitis and menometrorrhagia. Am J Ophthalmol 1997;123: 703-5.
69. De Bandt M, Perrot S, Masson C, Meyer O. Systemic sclerosis and sarcoidosis: a report of five cases. Br J Rheumatol 1997;36: 117-9.
70. Carmody RF, Mafee MF, Goodwin JA, Small K, Haery C. Orbital and optic pathway sarcoidosis: MR findings. AJNR Am J Neuroradiol 1994;15:775-83.
71. Westlake WH, Heath JD, Spalton DJ. Sarcoidosis involving the optic nerve and hypothalamus. Arch Ophthalmol 1995;113:669-70.
72. Mana J, Salazar A, Pujol R, Manresa F. Are the pulmonary function tests and the markers of activity helpful to establish the prognosis of sarcoidosis? Respiration 1996;63:298-303.
73. Agbogu BN, Stern BJ, Sewell C, Yang G. Therapeutic considerations in patients with refractory neurosarcoidosis. Arch Neurol 1995;52:875-9.
74. Power WJ, Neves RA, Rodriguez A, Pedroza-Seres M, Foster CS. The value of combined serum angiotensin-converting enzyme and gallium scan in diagnosing ocular sarcoidosis. Ophthalmology 1995;102:2007-11.
75. Wolfensberger TJ, Guex-Crosier Y, Herbert CP. Indocyanine green angiography (ICGA) features in ocular sarcoidosis. Poster presentation number 64 at the American Academy of Ophthalmology, San Francisco, October 1997.
76. Bacchella L, Tinelli C, Gile LS, et al. Serum Type I and Type III procollagen peptide levels in sarcoidosis. Eur Respir J 1996;9: 1648-51.
77. Sader A, Gramer E, Korner U. Sarcoidosis of the optic nerve. Klin Monatsblat Augenheilkd 1995;206:128-33.
78. Lower EE, Baughman RP. Prolonged use of methotrexate for sarcoidosis. Arch Intern Med 1995;155:846-51.
79. Gedalia A, Molina JF, Ellis GS Jr, Galen W, Moore C, Espinosa LR. Low dose methotrexate therapy for childhood sarcoidosis. J Pediatr 1997;130:25-9.
80. Brechtel B, Haas N, Henz BM, Kolde G. Allopurinol: a therapeutic alternative for disseminated cutaneous sarcoidosis. Br J Dermatol 1996;135:307-9.
81. Carlesimo M, Giustini S, Rossi A, Bonaccorsi P. Treatment of cutaneous and pulmonary sarcoidosis with thalidomide. J Am Acad Dermatol 1995;32(5, part 2):866-9.
82. Wei ME, Campbell SH, Taylor C. Precipitous visual loss secondary to optic nerve toxoplasmosis as an unusual presentation of AIDS. Aust N Z J Ophthalmol 1996;24(1):75-7.
83. Friedman SM, Margo CE. Bilateral central retinal vein occlusions in a patient with acquired immune deficiency syndrome: clinicopathologic correlation. Arch Ophthalmol 1995;113(9):1184-8.
84. Glasgow BJ. Evidence for breaches of the retinal vasculature in acquired immune deficiency syndrome angiopathy: a fluorescent microsphere study. Ophthalmology 1997;104(5):753-60.
85. Lee BL, Holland GN, Glasgow BJ. Chiasmal infarction and sudden blindness caused by mucormycosis. Am J Ophthalmol 1996; 122(6):895-6.
86. Font RL, Parsons MA, Keener MJ, et al. Involvement of anterior chamber angle structures in disseminated histoplasmosis: report of three cases. Ger J Ophthalmol 1995;4(2):107-15.
87. Heffler KF, Eckhardt TJ, Reboli AC, et al. Acanthamoeba endophthalmitis in acquired immune deficiency syndrome. Am J Ophthalmol 1996 122(4):584-66.
88. Kurumetry UR, Lustbader JM. Kaposi's sarcoma of the bulbar conjunctiva as an initial clinical manifestation of acquired immune deficiency syndrome. Arch Ophthalmol 1995;113(8):978.
89. Glasgow BJ, Engstrom RE Jr, Holland GN, Kreiger AE, Wool MG. Bilateral endogenous Fusarium endophthalmitis associated with acquired immunodeficiency syndrome. Arch Ophthalmol 1996;114(7):873-7.
90. Krzystolik MG, Kuperwasser M, Low RM, Dreyer EB. Anterior segment ultrasound biomicroscopy in a patient with AIDS and bilateral angle-closure glaucoma secondary to uveal effusions [Letter]. Arch Ophthalmol 1996;114(7):878-90.
91. Wilhemus KR, Font RL, Lehmann RP, Cernoch PL. Cytomegalovirus keratitis in acquired immunodeficiency syndrome [Clinical Conference]. Arch Ophthalmol 1996;114(7):869-72.
92. Roquer J, Palomeras E, Pou A. AIDS and cerebrovascular disease [Letter]. Stroke 1996;27(9):1694.
93. Pinto AN. AIDS and cerebrovascular disease. Stroke 1996;27(3): 538-43.
94. Zunker P, Nabavi DG, Allardt A, Husstedt IW. HIV-associated stroke: report of two unusual cases. Stroke 1996;27(9):1694-6.
95. Neal JW, Llewelyn MB, Morrison HL, et al. A malignant astrocytoma in a patient with AIDS: a possible association between Astrocytomas and HIV Infection. J Infect 1996;33:159-62.
96. Saito Y, Sharer LR, Epstein LG, et al. Over expression of NEF as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous system tissues. Neurology 1994;44:474-81.
97. Holloway RG, Mushlin AI. Intracranial mass lesions in acquired immunodeficiency syndrome: using decision analysis to determine the effectiveness of stereotactic brain biopsy. Neurology 1996;46(4):1010-5.
98. Heald AE, Hoffman JM, Bartlett JA, Waskin HA. Differentiation of central nervous system lesions in AIDS patients using positron emission tomography (PET). Int J STD AIDS 1996;7(5):337-46.
99. Laverda AM, Ruga E, Pagliaro A, et al. Intracranial hypertension and cryptococcal meningitis in a girl with AIDS. Brain Dev 1996;18:330-1.
100. Prevett MC, Plant GT. Intracranial hypertension and HIV associated meningoradiculitis. J Neurol Neurosurg Psychiatry 1997; 62(4):407-9.
101. Katlama C, Mouthon B, Gourdon D, et al. Atovaquone as long-term suppressive therapy for toxoplasmic encephalitis in patients with AIDS and multiple drug intolerance: Atovaquone Expanded Access Group. AIDS 1996;10(10):1107-12.
102. Ho D, Neumann AU, Perelson AS, et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995;373:123-6.
103. Wei X, Ghosh SK, Taylor ME, et al. Viral dynamics in human immunodeficiency virus Type 1 infection. Nature 1995;373:117-22.
104. Mellors JW, Kingsley LA, Rinald CR, et al. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995;122:573-9.
105. Phillips AN, Lee CA, Elford J, et al. Serial CD4 counts and development of AIDS. Lancet 1991;337:389-92.
106. Mellors JW, Rinaldo CR, Gupta P, et al. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996;272:1167-70.
107. Coombs RW, Welles SL, Hooper C. Association of plasma human immunodeficiency virus Type 1 RNA level with risk of clinical progression in patients with advanced infection. J Infect Dis 1996;174:704-12.
108. Carpenter CCJ, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1996: recommendations of an international panel. JAMA 1996;276:146-54.
109. Centurelli MA, Abate MA. The role of dehydroepiandrosterone in AIDS. Ann Pharmacol 1997;31(5):639-42.
110. Walker CM, Levy JA. A diffusible lymphokine produced by CD8+ T lymphocytes suppresses HIV replication. Immunology 1989;66:628-30.
111. Cocchi F, DeVico A, Garzino-Demo A, et al. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV suppressor factors produced by CD8+ T cells. Science 1995;270: 1811-5.
112. D'Souza MP, Harden VA. Chemokines and HIV-1 second receptors. Nat Med 1996;2(12):1293-1300.